Black patients who undergo minimally invasive procedures for clogged arteries are more likely to die or be readmitted to the hospital months after the procedure, a Michigan Medicine study finds.
Nov 22, 2022
0
2
For patients with multivessel coronary artery disease, the rates of major adverse cardiac events and safety events do not differ for those receiving percutaneous coronary intervention (PCI) with everolimus-eluting stent or ...
Oct 5, 2022
0
7
A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated significant improvement in cardiac output, left ventricular end diastolic pressure, and urine output in patients with ...
Sep 19, 2022
0
7
An intervention, including clinical decision support with audit and feedback, reduces the likelihood of acute kidney injury (AKI) among patients undergoing coronary angiography, according to a study published in the Sept. ...
Sep 6, 2022
0
9
For patients with intermediate coronary stenosis being evaluated for percutaneous coronary intervention (PCI), fractional flow reserve (FFR) guidance is noninferior to intravascular ultrasonography (IVUS) guidance for a composite ...
Sep 1, 2022
0
9
Radial artery access for coronary angiography or percutaneous coronary intervention (PCI) is associated with lower risks of all-cause death and bleeding compared with femoral access. That's the finding of late breaking research ...
Aug 30, 2022
0
2
Asundexian 50 mg administered to post-myocardial infarction patients inhibits factor XIa by more than 90% with no significant increase in bleeding, according to late breaking research presented in a Hot Line session on 28 ...
Aug 29, 2022
0
4
P2Y12 inhibitor monotherapy lowers the risk of ischemic events compared with aspirin alone in patients with coronary artery disease without increasing bleeding risk, according to late breaking research presented in a Hot ...
Aug 29, 2022
0
7
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking ...
Aug 29, 2022
0
13
A prespecified analysis of the MASTER DAPT trial has confirmed that the absence of ischemic risk and reduction in bleeding with abbreviated dual antiplatelet therapy (DAPT) in patients at high bleeding risk undergoing intervention ...
Aug 29, 2022
0
9
